For the quarter ended December 2025, CareDx (CDNA) reported revenue of $108.39 million, up 25.2% over the same period last year. EPS came in at $0.12, compared to $0.18 in the year-ago quarter.
The reported revenue represents a surprise of +5.66% over the Zacks Consensus Estimate of $102.58 million. With the consensus EPS estimate being $0.24, the EPS surprise was -48.94%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CareDx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for CareDx here>>>
Shares of CareDx have returned -9.7% over the past month versus the Zacks S&P 500 composite's -1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Nov-20 | |
| Nov-09 |
ARK Invest Dumps These Shares While They're Hot, Buys Chips The Size Of Your Face
CDNA +7.46%
Investor's Business Daily
|
| Nov-06 | |
| Nov-03 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-22 | |
| Oct-21 | |
| Oct-15 | |
| Sep-24 | |
| Aug-07 | |
| Aug-03 | |
| Jul-31 | |
| Jul-31 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite